Scholar Rock’s Retail Following Jumps 77% After Therapy Trial Win, Firm Announces $275M Share Sale

On Stocktwits, retail sentiment crashed to ‘extremely bearish’ levels from ‘extremely bullish’ a day earlier.
Representative image via Vecteezy
Representative image via Vecteezy
Profile Image
Ramakrishnan M·Stocktwits
Updated Mar 05, 2026   |   2:29 PM EST
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...

Shares of biotech firm Scholar Rock Holding Corp. ($SRRK) dropped more than 9% on Tuesday following a massive 300% surge the previous day.

The company unveiled a $275 million underwritten public offering. Scholar Rock plans to offer both common stock and pre-funded warrants to investors, and said it will use the proceeds to fund the commercialization of its lead muscle-targeted therapy, apitegromab, as well as other clinical programs.

The offering is being managed by J.P. Morgan Securities LLC, Jefferies LLC, and Piper Sandler & Co., with BMO Capital, Wedbush Securities, and Raymond James serving as co-managers.

Read Next
Loading...
Loading...

Advertisement|Remove ads.

SRRK sentiment and message volume Oct 8 .png
SRRK sentiment and message volume Oct 8 as of 11 am ET | source: Stocktwits.com

On Stocktwits, retail sentiment crashed to ‘extremely bearish’ (7/100) levels from ‘extremely bullish’ a day earlier following the news.

Advertisement|Remove ads.

Scholar Rock’s move comes on the heels of its recent breakthrough in the Phase 3 trial of apitegromab, designed to treat spinal muscular atrophy (SMA).

The trial results showed a significant improvement in motor function, sending the stock soaring to levels last seen in November 2021.

The stock’s dramatic rise has also drawn considerable attention from retail investors.

Advertisement|Remove ads.

The company’s following on Stocktwits surged by 77% within 24 hours of the trial announcement, while weekly message volume spiked by an astounding 117,700%.

SRRK shares are up over 75% year-to-date.

For updates and corrections email newsroom@stocktwits.com
 

Advertisement|Remove ads.

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.